iTeos Therapeutics, Inc. (DELISTED) (ITOS:DL)
10.15
0.00 (0.00%)
USD |
NASDAQ |
Sep 05, 16:00
iTeos Therapeutics Debt to Equity Ratio : 0.0104 for June 30, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2025 | 0.0104 |
| March 31, 2025 | 0.009 |
| December 31, 2024 | 0.0086 |
| September 30, 2024 | 0.0088 |
| June 30, 2024 | 0.0083 |
| March 31, 2024 | 0.0108 |
| December 31, 2023 | 0.0105 |
| September 30, 2023 | 0.0099 |
| June 30, 2023 | 0.0087 |
| March 31, 2023 | 0.0071 |
| December 31, 2022 | 0.007 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.0071 |
| June 30, 2022 | 0.0075 |
| March 31, 2022 | 0.0084 |
| December 31, 2021 | 0.0097 |
| September 30, 2021 | 0.0077 |
| June 30, 2021 | 0.0106 |
| March 31, 2021 | 0.0098 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ZimVie, Inc. (DELISTED) | 0.5682 |
| Sarepta Therapeutics, Inc. | 0.6845 |
| Black Titan Corp. | 0.00 |
| Solid Biosciences, Inc. | 0.0539 |
| Replimune Group, Inc. | 1.060 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 623.08M |
| Total Liabilities (Quarterly) | 129.28M |
| Shareholders Equity (Quarterly) | 493.80M |
| Current Ratio | 7.528 |
| Net Debt Paydown Yield | 0.03% |